Heron Therapeutics | HRTX - 净收入

金融业

USD 0.38

USD 252.26M

现金及等价物

USD 20.72M

USD 11.12M

USD 229.85M

USD 92.15M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 6.91M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 58M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 11.64M

应收帐款人

USD 89.59M

	净收入	更改		日
ALKERMES	USD 501K		66.98M	2026-06
Alnylam Pharmaceuticals	USD 164.49M		41.5M	2026-06
Amarin	USD -1.22M		6.51M	2025-12
ANI Pharmaceuticals	USD 24.71M		4.78M	2026-06
Anika Therapeutics	USD 292K		2.62M	2025-12
Arrowhead Research	USD -194.28M		61.55M	2026-06
Eisai	JPY 18.24B		21.49B	2026-06
Emergent BioSolutions	USD -261.3M		78.3M	2023-06
GlaxoSmithKline	GBP 435M		1.3B	2026-06
Heron Therapeutics	USD -2.95M		14.54M	2025-12
Insmed	USD -13.24M		150.32M	2026-06
Ligand Pharmaceuticals	USD 48.51M		61.85M	2026-06
Merck	USD -1.34B		2.9B	2026-06
Nektar Therapeutics	USD -44.9M		8.82M	2026-03
Neurocrine Biosciences	USD 144.4M		53.5M	2026-06
Omeros	USD -32.23M		23.81M	2024-09
Pacira	USD 4.65M		1.74M	2026-06
Regeneron Pharmaceuticals	USD 1.3B		569.7M	2026-06
Roche Holding	CHF 6.87B		1.4B	2026-06
Sangamo BioSciences	USD -36.13M		12.96M	2024-06
Ultragenyx Pharmaceutical	USD -185M		56M	2026-03
Veracyte	USD 25.49M		3.22M	2026-06
Vertex Pharmaceuticals	USD 1.1B		68.4M	2026-06